Phase 2/3Completed

Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza

A Randomized, Double-Blind, Placebo Controlled Study of Nitazoxanide in Adults and Adolescents With Acute Uncomplicated Influenza

Sponsor
Romark Laboratories L.C. (Industry)
Enrollment
624 enrolled
Conditions
Influenza
Interventions
Nitazoxanide; Nitazoxanide; Placebo
Ages
children, adults, older adults
Registry
NCT01227421

Full record on ClinicalTrials.gov

From the registry

This is a randomized clinical trial designed to evaluate the safety/efficacy of two dosing regimens of oral nitazoxanide compared to placebo in the treatment of acute uncomplicated influenza in adults and adolescents. The investigators hypothesize that treatment with Nitazoxanide will reduce the duration of symptoms in patients with confirmed influenza infection. Secondarily, the investigators hypothesize that treatment with nitazoxanide will reduce the complications of influenza, severity of symptoms, time lost from work, time to return to normal daily activities.

Primary outcomes

  • Time to Resolution of All Clinical Symptoms of Influenza as Reported by the Subjects

History

  1. Last registry update

  2. Results first posted

  3. Study completion

  4. Primary completion

  5. Started

  6. Registered